Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Why hasn t entresto's generic version been approved?Xarelto loss of exclusivity date?Bempedoic acid patent expiration date?Timoptic ocudose info?Lenacapavir generic availability date?
See the DrugPatentWatch profile for Apremilast
Apremilast’s brand name is Otezla (oral medication).
Otezla is used for inflammatory diseases, including: - Psoriatic arthritis - Plaque psoriasis - Behçet’s disease-related oral ulcers
Otezla is marketed by Bristol Myers Squibb.
This depends on whether a generic approval exists in the user’s country and timing versus exclusivity/patents. If you want, share your country and I can help narrow down what’s available there. For patent and market-tracking context, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/
Other Questions About Apremilast :